These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6155295)

  • 1. A study of the mechanism of lymphokine production and release.
    Korcáková L; Smetana K; Svobodová J
    Folia Biol (Praha); 1980; 26(2):140-4. PubMed ID: 6155295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of immunocompetent lymphocytes in vivo from murine umbilical cord blood cells.
    Oikawa A; Ito K; Seguchi H; Okabe M; Migishima F; Eshima K; Azuma S; Song SY; Kaneko T; Shinohara N
    Transplantation; 2007 Jul; 84(1):23-30. PubMed ID: 17627233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosette-increasing factor (RIF) generated in vivo following PHA skin test.
    Kubota M; Mikawa H
    Clin Exp Immunol; 1981 May; 44(2):315-23. PubMed ID: 6975675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subpopulations of lymphocytes to produce various lymphokines. I. Function of subpopulations separated by velocity sedimentation.
    Doroszczak N; Yoshida T; Cohen S
    J Immunol; 1977 Nov; 119(5):1617-20. PubMed ID: 334967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiproliferative lymphokine production by human peripheral blood lymphocytes and lymph node lymphocytes detected by a modified double layer soft agarose clonogenic assay.
    Saito T; Okadome M; Sugihara K; Sano M; Kamura T; Nakano H
    Lymphokine Cytokine Res; 1994 Feb; 13(1):55-62. PubMed ID: 8186325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PHA skin test-correlation with migration inhibition but not with peripheral blood lymphocytes (PBL) subpopulations. With 1 figure.
    Szczylik C; Wiktor-Jedrzejczak W
    Allerg Immunol (Leipz); 1981; 27(3):162-7. PubMed ID: 6214937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed lymphocyte reaction and skin graft using HLA-DP and DQ transgenic mice.
    Hagihara M; Shimura T; Tsuchida F; Takebe K; Munkhbat B; Tsuji K
    Transplant Proc; 1994 Aug; 26(4):1868. PubMed ID: 8066607
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanism of lymphocyte activation. II. Requirements for macromolecular synthesis in the production of lymphokines.
    Varesio L; Holden HT; Taramelli D
    J Immunol; 1980 Dec; 125(6):2810-7. PubMed ID: 6159423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphokine (interleukin-2) production by mitogen-stimulated human lymphocytes in small reactors.
    Bödeker BG; Lehmann J; Mühlradt PF
    Dev Biol Stand; 1981; 50():193-200. PubMed ID: 6978826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node activation by a factor released from lymphocytes of normal mice in reaction with Mycobacterium kansasii.
    Korcáková L; Kubín M; Paluska E
    Folia Biol (Praha); 1979; 25(2):107-15. PubMed ID: 156656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic conditions for the release of a lymphokine "lymph node activating factor".
    Capková J; Korcáková L; Paluska E; Hasková V
    Folia Biol (Praha); 1981; 27(4):233-9. PubMed ID: 6456156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of E-rosette formation by mitogen-stimulated canine lymphocytes.
    Krakowka S
    Immunology; 1980 Feb; 39(2):255-61. PubMed ID: 7380469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular interactions in spontaneous or autologous cell-induced proliferative and lymphokine responses of human lymphocytes.
    Arvilommi H; Räsänen L
    Immunology; 1980 Aug; 40(4):695-700. PubMed ID: 6448804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of ampicillin on the response of human lymphocytes to PHA.
    Wojtulewicz-Kurkus J; Skopińska-Rózewska EU; Norwaczyk M; Podobińska I
    Arch Immunol Ther Exp (Warsz); 1981; 29(3):361-8. PubMed ID: 7294972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of HLA class II antigens/genes in xenogeneic iso, allo, and xeno transplantation.
    Tsuji K; Hagihara M; Sato T; Shimura T; Takebe K; Munkhbat B
    Transplant Proc; 1994 Aug; 26(4):2441-3. PubMed ID: 8066801
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of phytohaemagglutinin-induced autorosette formation of human peripheral blood lymphocytes by RNA or protein synthesis inhibitor.
    Hyodo S; Kishi T; Kittaka E; Suzawa T; Tanabe A; Tanaka Y; Sakano T; Usui T
    Clin Exp Immunol; 1983 Jul; 53(1):140-4. PubMed ID: 6191894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a lymphokine enhancing arginase activity during allograft rejection.
    Dy M; Schneider E; Mavier P; Kamoun P; Lebel B; Hamburger J
    J Immunol; 1983 Apr; 130(4):1937-42. PubMed ID: 6187826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cellular regulation of human lymphocyte mitogenic factor release in vitro].
    Voĭteniuk NN; Varivotskaia NV
    Biull Eksp Biol Med; 1979 Dec; 88(12):720-2. PubMed ID: 391297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 2 enhancement of lymphokine secretion by T lymphocytes: analysis of established clones and primary limiting dilution microcultures.
    Kelso A; MacDonald HR; Smith KA; Cerottini JC; Brunner KT
    J Immunol; 1984 Jun; 132(6):2932-8. PubMed ID: 6233365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A human lymphocyte chemotactic factor produced by the mixed lymphocyte reaction.
    El-Naggar A; Van Epps DE; Williams RC
    J Lab Clin Med; 1982 Oct; 100(4):558-65. PubMed ID: 6214599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.